« Return to News | Drug Sponsors

Takeda denies takeover of Nycomed

Friday, May 13, 2011 11:35 AM

Japan-based Takeda Pharmaceutical has denied rumors of a $12.3 billion takeover of Switzerland-based Nycomed, according to Pharma Times.

Yesterday, Takeda was front-page news regarding the potential deal to buy privately-owned Nycomed. However, Takeda has made a statement saying it "has and always will comply with the rules governing the publication of any event of material significance to our business and our shareholders." Takeda emphatically stated, "the company would like to make clear that Takeda has not agreed to any such an agreement as suggested by certain newspaper publications."

While the company stressed "a policy of not commenting on any rumors regarding our business," Takeda noted that it is "constantly seeking and evaluating opportunities to increase shareholder value and enhance our business through strategic investment." However, "there is nothing that needs to be announced at this point."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.